Clinical Trial Update: FUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR (Nesiritide) Administered to Patients With Worsening Congestive (Decompensated) Heart Failure Who Are Concurrently Receiving Their Usual Cardiac Medications and Are at High Risk for Hospitalization. [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 study evaluating the safety and tolerability of two doses of nesiritide (NATRECOR) in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Natrecor (nesiritide)

Snippet

Sponsor: Scios, Inc. | Conditions: Heart Failure, Congestive | Phase 3 | Status: COMPLETED